Onchocerciasis Treatment Market Report 2026
Onchocerciasis Treatment Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Onchocerciasis Treatment Market Report 2026

Global Outlook – By Drug Type (Ivermectin, Doxycycline, Albendazole, Moxidectin), By Treatment Strategy (Mass Drug Administration (MDA), Targeted Treatment), By Mode Of Administration (Oral, Injectables, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Onchocerciasis Treatment Market Overview

• Onchocerciasis Treatment market size has reached to $1.11 billion in 2025

• Expected to grow to $1.59 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Surge In Eye-related Conditions Fueling Growth Of The Market Due To Rising Risk Of Vision Loss

• Market Trend: Novel Antiparasitic Medications Driving Growth In The Market Through Improved Efficacy And Access

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Onchocerciasis Treatment Market?

Onchocerciasis treatment refers to the medical and therapeutic interventions designed to manage and eliminate onchocerca volvulus infections, which cause river blindness a parasitic disease primarily affecting skin and eye health. The primary goal of treatment is to eliminate the microfilariae (immature larvae) and reduce transmission, symptoms, and the risk of vision loss.

The main drug types of onchocerciasis treatment are ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic medication used to treat various parasitic infections, including onchocerciasis (river blindness), by killing the larvae (microfilariae) of the parasite Onchocerca volvulus. The treatment strategies include mass drug administration (MDA) and targeted treatment, with modes of administration including oral, injectable, and topical forms. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies and are used by various end-users such as hospitals and clinics, home care settings, and government and non-governmental programs.

Onchocerciasis Treatment Market Global Report 2026 Market Report bar graph

What Is The Onchocerciasis Treatment Market Size and Share 2026?

The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.11 billion in 2025 to $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to limited availability of ivermectin and doxycycline in endemic regions, reliance on hospital-based distribution channels, low awareness of onchocerciasis management, inadequate preventive chemotherapy programs, dependency on oral formulations only.

What Is The Onchocerciasis Treatment Market Growth Forecast?

The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to introduction of moxidectin and long-acting formulations, expansion of online and retail pharmacy distribution, development of combination therapies, increased government and NGO funding for eradication programs, adoption of community-based preventive strategies. Major trends in the forecast period include expansion of mass drug administration (mda) programs, development of pediatric and fixed-dose formulations, increased focus on anti-wolbachia therapies, integration of oral and injectable treatment regimens, growth of community-based and government-supported treatment campaigns.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Onchocerciasis Treatment Market Segmentation

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

What Are The Drivers Of The Onchocerciasis Treatment Market?

The rise in patients suffering from eye-associated issues is expected to propel the growth of the onchocerciasis treatment market going forward. Eye-associated issues refer to a variety of conditions that affect vision and ocular health, including infections, injuries, and chronic illnesses such as glaucoma or cataracts. The growth in patients suffering from eye-associated issues is primarily due to increasing screen time and prolonged exposure to digital devices. Onchocerciasis treatment helps prevent and manage vision loss and blindness in patients by eliminating the parasitic infection that causes inflammation and damage to ocular tissues. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, about 20.5 million Americans over the age of 40 have cataracts in at least one eye, accounting for 17.2% of that population. It is projected that nearly 30 million people will develop cataracts by 2028. Therefore, the rising prevalence of eye-related conditions is driving growth in the onchocerciasis treatment industry.

The rising demand for surgical procedures is expected to propel the growth of the onchocerciasis treatment market going forward. Surgical procedures refer to medical interventions aimed at removing or repairing tissues damaged by disease, often used when drug treatments are ineffective or when complications threaten long-term health. This rise is driven by the progression of onchocerciasis in some patients to advanced stages, where surgical intervention becomes necessary to prevent permanent damage, such as vision loss or disfigurement. As a result, healthcare providers are expanding surgical services and investing in advanced techniques, thereby boosting the overall market for onchocerciasis treatment. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, in 2023, nearly 35 million aesthetic procedures were performed worldwide, a 3.4% increase from 2022. The report also highlighted that surgical procedures rose by 5.5%, with more than 15.8 million procedures performed by plastic surgeons. Therefore, the rising demand for surgical procedures is driving growth in the onchocerciasis treatment industry.

Key Players In The Global Onchocerciasis Treatment Market

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Global Onchocerciasis Treatment Market Trends and Insights

Major companies operating in the onchocerciasis treatment market are focusing on developing novel antiparasitic medications to improve treatment effectiveness and reduce duration. Antiparasitic medications are drugs designed to eliminate or inhibit parasites such as worms and protozoa that cause infections in humans. For instance, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical company, received approval from the Ghana Food and Drugs Authority (FDA) for Moxidectin 2 mg oral tablets to treat river blindness in individuals aged 4 years and older. This approval enables Ghana to implement community-based mass drug administration programs using moxidectin, which offers greater efficacy and longer-lasting effects compared to ivermectin. With this approval, MDGH aims to expand access to an effective new treatment for onchocerciasis, enabling large-scale community programs in endemic regions.

Need data on a specific region in this market?

Regional Insights

North America was the largest region in the onchocerciasis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Onchocerciasis Treatment Market?

The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Onchocerciasis Treatment Market Report 2026?

The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Onchocerciasis Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.19 billion
Revenue Forecast In 2035 $1.59 billion
Growth Rate CAGR of 7.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Type, Treatment Strategy, Mode Of Administration, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunob
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Onchocerciasis Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Onchocerciasis Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Onchocerciasis Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Onchocerciasis Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Mass Drug Administration (Mda) Programs

4.2.2 Development Of Pediatric And Fixed-Dose Formulations

4.2.3 Increased Focus On Anti-Wolbachia Therapies

4.2.4 Integration Of Oral And Injectable Treatment Regimens

4.2.5 Growth Of Community-Based And Government-Supported Treatment Campaigns

5. Onchocerciasis Treatment Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Home Care Settings

5.3 Government Programs

5.4 Non-Governmental Organizations (Ngos)

5.5 Community Health Centers

6. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Onchocerciasis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Onchocerciasis Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Onchocerciasis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Onchocerciasis Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Onchocerciasis Treatment Market Segmentation

9.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ivermectin, Doxycycline, Albendazole, Moxidectin

9.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mass Drug Administration (MDA), Targeted Treatment

9.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectables, Topical

9.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

9.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

9.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

9.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

9.9. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

10. Onchocerciasis Treatment Market Regional And Country Analysis

10.1. Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Onchocerciasis Treatment Market

11.1. Asia-Pacific Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Onchocerciasis Treatment Market

12.1. China Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Onchocerciasis Treatment Market

13.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Onchocerciasis Treatment Market

14.1. Japan Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Onchocerciasis Treatment Market

15.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Onchocerciasis Treatment Market

16.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Onchocerciasis Treatment Market

17.1. South Korea Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Onchocerciasis Treatment Market

18.1. Taiwan Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Onchocerciasis Treatment Market

19.1. South East Asia Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Onchocerciasis Treatment Market

20.1. Western Europe Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Onchocerciasis Treatment Market

21.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Onchocerciasis Treatment Market

22.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Onchocerciasis Treatment Market

23.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Onchocerciasis Treatment Market

24.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Onchocerciasis Treatment Market

25.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Onchocerciasis Treatment Market

26.1. Eastern Europe Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Onchocerciasis Treatment Market

27.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Onchocerciasis Treatment Market

28.1. North America Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Onchocerciasis Treatment Market

29.1. USA Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Onchocerciasis Treatment Market

30.1. Canada Onchocerciasis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Onchocerciasis Treatment Market

31.1. South America Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Onchocerciasis Treatment Market

32.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Onchocerciasis Treatment Market

33.1. Middle East Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Onchocerciasis Treatment Market

34.1. Africa Onchocerciasis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Onchocerciasis Treatment Market Regulatory and Investment Landscape

36. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles

36.1. Onchocerciasis Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Onchocerciasis Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Onchocerciasis Treatment Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Hetero Labs Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Onchocerciasis Treatment Market Other Major And Innovative Companies

Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

38. Global Onchocerciasis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Onchocerciasis Treatment Market

40. Onchocerciasis Treatment Market High Potential Countries, Segments and Strategies

40.1 Onchocerciasis Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Onchocerciasis Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Onchocerciasis Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Onchocerciasis Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Onchocerciasis Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Onchocerciasis Treatment Market, Supply Chain Analysis
  • Table 4: Global Onchocerciasis Treatment Market, Major Raw Material Providers
  • Table 5: Global Onchocerciasis Treatment Market, Major Resource Providers
  • Table 6: Global Onchocerciasis Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Onchocerciasis Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Onchocerciasis Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Onchocerciasis Treatment Market, Major Trends
  • Table 10: Global Onchocerciasis Treatment Market, Major End Users
  • Table 11: Global Onchocerciasis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Onchocerciasis Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Onchocerciasis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Onchocerciasis Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Onchocerciasis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Onchocerciasis Treatment Market - Company Scoring Matrix
  • Table 100: Merck & Co. Inc. Financial Performance
  • Table 101: Teva Pharmaceutical Industries Limited Financial Performance
  • Table 102: Hetero Labs Limited Financial Performance
  • Table 103: Sun Pharmaceutical Industries Limited Financial Performance
  • Table 104: Intas Pharmaceuticals Limited Financial Performance
  • Table 105: Global Onchocerciasis Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Onchocerciasis Treatment Market, Competitive Dashboard
  • Table 107: Global Onchocerciasis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 109: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Treatment Strategy, 2025 – 2030
  • Table 110: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Mode Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Onchocerciasis Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Onchocerciasis Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Onchocerciasis Treatment Market, Supply Chain Analysis
  • Figure 4: Global Onchocerciasis Treatment Market, Major Raw Material Providers
  • Figure 5: Global Onchocerciasis Treatment Market, Major Resource Providers
  • Figure 6: Global Onchocerciasis Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Onchocerciasis Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Onchocerciasis Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Onchocerciasis Treatment Market, Major Trends
  • Figure 10: Global Onchocerciasis Treatment Market, Major End Users
  • Figure 11: Global Onchocerciasis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Onchocerciasis Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Onchocerciasis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Onchocerciasis Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Onchocerciasis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Onchocerciasis Treatment Market - Company Scoring Matrix
  • Figure 100: Merck & Co. Inc. Financial Performance
  • Figure 101: Teva Pharmaceutical Industries Limited Financial Performance
  • Figure 102: Hetero Labs Limited Financial Performance
  • Figure 103: Sun Pharmaceutical Industries Limited Financial Performance
  • Figure 104: Intas Pharmaceuticals Limited Financial Performance
  • Figure 105: Global Onchocerciasis Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Onchocerciasis Treatment Market, Competitive Dashboard
  • Figure 107: Global Onchocerciasis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 109: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Treatment Strategy, 2025 – 2030
  • Figure 110: Global, Onchocerciasis Treatment Market Size Gain ($ Billion), Segmentation By Mode Of Administration, 2025 – 2030

Frequently Asked Questions

The Onchocerciasis Treatment market was valued at $1.11 billion in 2025, increased to $1.19 billion in 2026, and is projected to reach $1.59 billion by 2030.

The global Onchocerciasis Treatment market is expected to grow at a CAGR of 7.4% from 2026 to 2035 to reach $1.59 billion by 2035.

Some Key Players in the Onchocerciasis Treatment market Include, Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc. .

Major trend in this market includes: Novel Antiparasitic Medications Driving Growth In The Market Through Improved Efficacy And Access. For further insights on this market. request a sample here

North America was the largest region in the onchocerciasis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts